Top compounds associated with response to RNLS


Feature Type Standardized
Nominal ANOVA
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC -0.12 0.0001
mRNA QL-X-138 GDSC1000 pan-cancer AAC -0.11 0.0001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA SB-225002 CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA OSI-027 GDSC1000 pan-cancer AAC -0.11 0.0002
mRNA PI-103 GDSC1000 pan-cancer AAC -0.11 0.0002
mRNA brivanib CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA ML239 CTRPv2 pan-cancer AAC -0.13 0.0004
Download CSV